Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;52(2):399-406.
doi: 10.18502/ijph.v52i2.11893.

Economic Burden of HIV/AIDS in Iran: A Modelling Approach

Hesam Ghiasvand  1 , Jebreil Shamseddin  2 , Seyran Naghdi  3 , Akbar Biglarian  4
Affiliations

Economic Burden of HIV/AIDS in Iran: A Modelling Approach

Hesam Ghiasvand et al. Iran J Public Health. 2023 Feb.

Abstract

Background: HIV/AIDS is a leading cause of mortality and morbidity in Low-and-Middle-Income-Countries (LMICs). It might potentially lead to an economic burden on the health system. There is no certainty about the prevalence of HIV/AIDS in Iran. Therefore, we aimed to estimate the cost of illness of HIV/AIDS in Iran.

Methods: We applied a societal perspective to capture the direct and indirect costs attributed to HIV/AIDS in Iran. We used data for age-standardized prevalence produced by the country HIV/AIDS Surveillance System for 2018. The study estimated both direct and indirect costs for a hypothetical cohort of the Iranian adult population (here equates to all registered cases with Surveillance System). For mitigating the uncertainty around the estimations, we have used an optimistic and pessimistic analysis.

Results: The base case scenario showed that total direct costs and indirect costs attributed to the HIV/AIDS were US$7,946,530 and US$ 1,288,586 at the end of 2018. Moreover, the total cost is 8,785,116 US$.

Conclusion: Direct costs have formed approximately 85% of total costs. The policymakers and planners should consider that these costs are only related to diagnosed or registered infected populations. These costs will be raised dramatically with increasing the diagnosed patients.

Keywords: Antiretroviral therapy; Cost of illness; Economic burden; HIV/AIDS.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare that there is no conflict of interests.

Figures

Fig. 1:
Fig. 1:
Model structure of economic burden of HIV/AIDS
See this image and copyright information in PMC

References

    1. Gona PN, Gona CM, Ballout S, et al. (2020). Burden and changes in HIV/AIDS morbidity and mortality in Southern Africa Development Community Countries, 1990–2017. BMC Public Health, 20(1):867. - PMC - PubMed
    1. Saeed SM, Ayuwat D. (2020). A Qualitative Study of Stigma Experience by Households with People Living With HIV/AIDS in Kaduna State, Nigeria. Systematic Reviews in Pharmacy, 11:1320–1328.
    1. Nketiah-Amponsah E, Abubakari M, Baffour PT. (2019). Effect of HIV/AIDS on Economic Growth in Sub-Saharan Africa: Recent Evidence. Int Adv Econ Res, 25:469–480.
    1. Frank TD, Carter A, Jahagirdar D, et al. (2019). Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. The Lancet HIV, 6:e831–e859. - PMC - PubMed
    1. Jahagirdar D, Walters MK, Novotney A, et al. (2021). Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019. The Lancet HIV, 8:e633–e651. - PMC - PubMed

LinkOut - more resources